lOMoARcPSD|23780900
ACTIVE LEARNING TEMPLATE:
Medication
STUDENT NAME _____________________________________
MEDICATION __________________________________________________________________________
REVIEW MODULE CHAPTER ___________
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action
Dopamine D2 and Serotonin 5-HT1A agonist
5-HT2A antagonist
alpha1 adrenergic blocking activity
Therapeutic Use
decreased manifestations of schizophrenia
decreased mania in bipolar patients
decreased symptoms of depression, agitation, tics,
irritability
Route
Complications
suicidal thoughts, agranulocytosis, hypersensitivity
reactions, neruoleptic malignant syndrome
IM or PO
Contraindications/Precautions
use of CYP3A4 inhibitors/inducers
use of CYP2D6 inhibitors
hypertension, diabetes
Nursing Interventions
assess mental status
monitor for development of
neuroleptic malignant syndrome
Interactions
do not confuse with rabeprazole
ketoconazole, clarithromycin, quinidine, fluoxetine,
paroxetine, carbamazepine
Client Education
Dosage
target dose range 10-15mg/day
comes as 2, 5, 10, 15, 20, 30 mg
notify provider of suicidal
thoughts, trouble sleeping,
worsening symptoms